QGEN (Qiagen Group) Total Business Assets

QGEN (Qiagen NV) - company brandmark

This chart illustrates the dynamics of total assets for Qiagen N.V. (QGEN), which currently stand at 5855.79. The business relies on a complex reagent transportation system with strict temperature controls. Qiagen N.V. (QGEN) maintains its technological edge through large-scale investments in the development of genetic analysis systems. High switching costs allow the firm to confidently exercise pricing power over its specialized products.

QGEN - Qiagen N.V. Company Total Assets over the range 07/04/2022 - 10/31/2026
Original product of Qiagen N.V.

Total assets represent the aggregate value of the company's resources, calculated inversely via return on assets (ROA). This indicator separates real operating capacity from market volatility, visualizing the growth of all company resources on the GURU.Markets platform. For Qiagen N.V. (QGEN), excess capital amid falling post-pandemic revenues increases the risk of a drawdown. High costs associated with DNA development make monitoring this metric critical for assessing return on investment.

Direct competitors

Total Business Assets TEM|IONS (Ionis) - Company Total Assets|Total Business Assets RGEN (Repligen Corp)|Aggregate Company Assets Avidity (RNA)|CRISPR - Total Business Assets|Company Total Assets WGS (GeneDx Holdings Corp.)|Company Total Assets ultragenyx.com RARE|BEAM - Aggregate Company Assets|Company Balance Sheet Assets Sarepta Therapeutics (SRPT)|TWST: Company Total Assets|TXG - Company Total Asset Base|NTLA (Intellia Therapeutics) - Company Total Assets|Company Total Assets stoketherapeutics.com|Company Total Assets BLFS|Wave Life Sciences Ltd (WVE) - Company Balance Sheet Assets|Company Total Assets MAZE (Maze Tx)|Sionna Corp (SION) - Company Assets|PRME - Aggregate Company Assets|TSHA (tayshagtx.com) - Total Business Assets|QURE (uniQure) - Cumulative Company Assets|MeiraGTx Holdings - Aggregate Asset Value|Aggregate Company Assets Regenxbio|Total Business Assets SLDB (Solid Corp)|Cumulative Company Assets OCGN (Ocugen, Inc.)|Company Total Asset Base pacb.com|Benitec Biopharma - Cumulative Company Assets|Design Therapeutics Inc - Aggregate Company Assets|RCKT: Cumulative Company Assets|Company Total Asset Base 4D Molecular Corp FDMT|lexeotx.com (LXEO) - Aggregate Company Assets|Company Balance Sheet Assets Korro Bio KRRO|EDIT (Editas Medicine) - Company Total Assets|SLN - Company Balance Sheet Assets|Company Total Assets PRQR|CDXS - Company Assets|Aggregate Company Assets Sangamo Therapeutics SGMO|NAUT: Total Business Assets|Metagenomi - Company Total Assets|DTIL (precisionbiosciences.com) - Total Business Assets|generationbio.com (GBIO) - Aggregate Company Assets|Total Business Assets BOLD|XCUR (Exicure Inc.) - Company Total Assets|Company Total Assets Celsion Corporation|Aggregate Company Assets Phio Pharmaceuticals (PHIO)|mustangbio.com (MBIO) - Company Balance Sheet Assets|Company Total Assets RNAZ (TransCode Therapeutics, Inc.)|Company Total Asset Base Bionano Genomics Inc. (BNGO)|Applied DNA Sciences - Company Total Assets|BLUE - Company Total Assets|IPA: Company Total Assets|Company Balance Sheet Assets Omega Therapeutics Inc OMGA|OMIC (Singular Genomics Systems Inc) - Company Total Assets|Company Assets Regulus RGLS|Aggregate Company Assets Syros Pharmaceuticals (SYRS)|telesisbio.com - Total Business Assets|TRACON Pharmaceuticals, Inc. - Cumulative Company Assets|Aggregate Asset Value UBX